US 12,264,165 B2
Process for the stereoselective preparation of chiral 2-[(hetero) arylalkylsulfanyl]pyrimidines and products obtainable therefrom
Jan Vågberg, Solna (SE); and Styrbjörn Byström, Solna (SE)
Assigned to Kancera AB, Solna (SE)
Filed by KANCERA AB, Solna (SE)
Filed on May 19, 2023, as Appl. No. 18/199,899.
Application 18/199,899 is a continuation of application No. 17/966,294, filed on Oct. 14, 2022, granted, now 11,691,988.
Application 17/966,294 is a continuation of application No. 17/055,172, granted, now 11,542,281, issued on Jan. 3, 2023, previously published as PCT/EP2019/062530, filed on May 15, 2019.
Claims priority of application No. 1807898 (GB), filed on May 15, 2018.
Prior Publication US 2023/0322807 A1, Oct. 12, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 513/04 (2006.01); C07D 239/56 (2006.01)
CPC C07D 513/04 (2013.01) [C07D 239/56 (2013.01)] 4 Claims
 
1. A compound having a structure:

OG Complex Work Unit Chemistry
or a salt thereof, with a chiral purity of greater than 99.7%.